European Journal of Pharmacology 1994: Vol 269 Index

5 Pages·1994·1.5 MB·English

Op
European Journal of Pharmacology molecular pharmacology
Molecular Pharmacology Section 269 (1994) 385-388
Author index
Adachi, M., Furuichi, Y. and Miyamoto, C. Branchek, T.A., see Borden, L.A. (269) 219
Identification of a region of the human endothelin ET, receptor Bridges, R.J., see Miller, S. (269) 235
required for interaction with bosentan (269) 225 Browning, M.D., see Firestone, J.A. (269) 177
Adan, R.A.H., Oosterom, J., Ludvigsdottir, G., Brakkee, J.H., Bur- Burbach, J.P.H., see Adan, R.A.H. (269) 331
bach, J.P.H. and Gispen, W.H. Burnett, J.P., see Sharp, R.L. (269) R5
Identification of antagonists for melanocortin MC,, MC, and Butt, E., Eigenthaler, M. and Genieser, H.-G.
MC, receptors (269) 331 (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase
Agbotounou, W.K., Umezawa, K., Jacquemin-Sablon, A. and Pierre, inhibitor (269) 265
J.
Inhibition by two lavendustins of the tyrosine kinase activity of
Cavanni, P., Pinnola, V., Mugnaini, M., Trist, D., Van Amsterdam,
pp60*>?’ in vitro and in intact cells (269) 1
F.Th.M. and Ferraguti, F.
Akishita, M., see Ishikawa, M. (269) 311
Pharmacological analysis of carboxyphenylglycines at metabo-
Akiyama, T., see Nakazawa, K. (269) 375
tropic glutamate receptors (269) 9
Ambrosio, C., see Roscetti, G. (269) 17
Chamberlin, A.R., see Miller, S. (269) 235
Amiranoff, B., see Heuillet, E. (269) 139
Chen, T.-S., see Koutsilieri, E. (269) R3
Amiranoff, B., see Lorinet, A.-M. (269) 59
Chung, F.-Z., see Pinnock, R.D. (269) 73
Aramori, I., Morikawa, N., Zenkoh, J., O’Donnell, N., Iwami, M., Chung, F.-Z., see Suman-Chauhan, N. (269) 65
Kojo, H., Notsu, Y., Okuhara, M., Ono, S. and Nakanishi, S.
Classen, M., see Schepp, W. (269) 183
Subtype- and species-selectivity of a tachykinin receptor antago- Cotman, C.W., see Miller, S. (269) 235
nist, FK888, for cloned rat and human tachykinin receptors (269)
Craig, C.G., Temple, $.D. and White, T.D.
277
Is cyclic AMP involved in excitatory amino acid-evoked adeno-
Audus, K.L., see Borges, N. (269) 243
sine release from rat cortical slices? (269) 79
Azevedo, I., see Borges, N. (269) 243
Crespo, A., see Heuillet, E. (269) 139
Barbaccia, M.L., see Roscetti, G. (269) 17
Daviaud, D., see Bouloumié, A. (269) 95
Barnes, P.J., see Mak, J.C.W. (269) 35
De Boer, T., see Stam, N.J. (269) 339
Baron, A., Rakotoarisoa, L., Leprétre, N. and Mironneau, J.
Dehne, K., see Schepp, W. (269) 183
Inhibition of L-type Ca?* channels in portal vein myocytes by the
Dhar, T.G.M., see Borden, L.A. (269) 219
enantiomers of oxodipine (269) 105
Doble, A., see Heuillet, E. (269) 139
Baudry, M., see Marvizon, J.-C. (269) 165
Drejer, J., see Verdoorn, T.A. (269) 43
Beart, P.M., Ryan, M.C., Mercer, L.D., Jarrott, B. and Wong, M.G.
Droogmans, G., see Gericke, M. (269) 381
Heterocyclic amino alcohols related to ifenprodil as o receptor
Drukarch, B., see Vermeulen, R.J. (269) 121
ligands: binding and conformational analyses (269) 193
Dubois, H., see Heuillet, E. (269) 139
Billecocq, A., Hedlund, P.B., Bolanos-Jiménez, F. and Fillion, G.
Dugay, P., see Heuillet, E. (269) 139
Characterization of galanin and 5-HT,, receptor coupling to
adenylyl cyclase in discrete regions of the rat brain (269) 209
Eigenthaler, M., see Butt, E. (269) 265
Blanchard, J.-C., see Heuillet, E. (269) 139
Bolanos-Jiménez, F., see Billecocg, A. (269) 209 Eng, J., see Schepp, W. (269) 183
Eysselein, V.E., see Grandt, D. (269) 127
Bolger, M.B., see Hawkinson, J.E. (269) 157
Borden, L.A., Dhar, T.G.M., Smith, K.E., Weinshank, R.L.,
Branchek, T.A. and Gluchowski, C. Fang, S., see Knapp, R.J. (269) 133
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective Ferraguti, F., see Cavanni, P. (269) 9
for the cloned GABA transporter GAT-1 (269) 219 Feth, F., see Grandt, D. (269) 127
Borges, N., Shi, F., Azevedo, I. and Audus, K.L. Fillion, G., see Billecocq, A. (269) 209
Changes in brain microvessel endothelial cell monolayer perme- Filloux, F.M., Fitts, R.C., Skeen, G.A. and White, H.S.
ability induced by adrenergic drugs (269) 243 The dihydropyridine nitrendipine inhibits [>H]MK 801 binding to
Bouaiche, Z., see Heuillet, E. (269) 139 mouse brain sections (269) 325
Bouloumié, A., Valet, P., Daviaud, D., Prats, H., Lafontan, M. and Firestone, J.A., Marks, M.J., Gerhardt, G.A. and Browning, M.D.
Saulnier-Blache, J.-S. ABT-200, a norepinephrine uptake inhibitor, blocks Ca?* signals
Adipocyte a@>,-adrenoceptor is the only a -adrenoceptor regu- in chromaffin cells (269) 177
lated by testosterone (269) 95 Fitts, R.C., see Filloux, F.M. (269) 325
Brakkee, J.H., see Adan, R.A.H. (269) 331 Furuichi, Y., see Adachi, M. (269) 225
386 Author index / European Journal of Pharmacology — Molecular Pharmacology Section 269 (1994) 385-388
Gee, K.W., see Hawkinson, J.E. (269) 157 Knapp, R.J., Malatynska, E., Peterson, P., Zalewska, T., Fang, S.,
Genieser, H.-G., see Butt, E. (269) 265 Hruby, V.J., Smith, T.L. and Yamamura, H.I.
George, S.R., see Ng, G.YK. (269) 349 [N -Methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702)
George, S.R., see Ng, G.YK. (269) 365 activity at a cloned rat CCK , receptor (269) 133
Gerhardt, G.A., see Firestone, J.A. (269) 177 Koike, H., Imanishi, N., Natsume, Y. and Morooka, S.
Gericke, M., Oike, M., Droogmans, G. and Nilius, B. Effects of platelet activating factor receptor antagonists on intra-
Inhibition of capacitative Ca2* entry by a Cl~ channel blocker in cellular platelet activating factor function in neutrophils (269) 299
human endothelial cells (269) 381 Kojima, I., see Mogami, H. (269) 293
Gies, J.-P., see Lach, E. (269) 87 Kojo, H., see Aramori, I. (269) 277
Gispen, W.H., see Adan, R.A.H. (269) 331 Koutsilieri, E., O’Callaghan, J.F.X., Chen, T.-S., Riederer, P. and
Gluchowski, C., see Borden, L.A. (269) 219 Rausch, W.-D.
Goebell, H., see Grandt, D. (269) 127 Selegiline enhances survival and neurite outgrowth of MPP*-
Grandordy, B., see Mak, J.C.W. (269) 35 treated dopaminergic neurons (269) R3
Grandt, D., Feth, F., Rascher, W., Reeve Jr., J.R., Schlicker, E., Kozaki, K., see Ishikawa, M. (269) 311
Schimiczek, M., Layer, P., Goebell, H., Eysselein, V.E. and Kuoppamaki, M., Seppala, T., Syvalahti, E. and Hietala, J.
Michel, M.C. Regulation of serotonin 5-HT < receptors in the rat choroid
[Pro**]peptide YY is a Y,-selective agonist at peptide YY /neu- plexus after acute clozapine treatment (269) 201
ropeptide Y receptors (269) 127
Grimson, P., see Suman-Chauhan, N. (269) 65
Laburthe, M., see Lorinet, A.-M. (269) 59
Guard, S., see Suman-Chauhan, N. (269) 65
Lach, E., Trifilieff, A., Scherrer, D. and Gies, J.-P.
Association of guinea pig lung bombesin receptors with pertussis
Hamaguchi, A., see Ohta, K. (269) 115
toxin-sensitive guanine nucleotide binding proteins (269) 87
Han, S.-z., see Ishikawa, M. (269) 311
Lafontan, M., see Bouloumié, A. (269) 95
Hawkinson, J.E., Kimbrough, C.L., McCauley, L.D., Bolger, M.B., Lan, N.C., see Hawkinson, J.E. (269) 157
Lan, N.C. and Gee, K.W.
Langeveld, C.H., see Vermeulen, R.J. (269) 121
The neuroactive steroid 3a-hydroxy-58-pregnan-20-one is a two- Lavayre, J., see Heuillet, E. (269) 139
component modulator of ligand binding to the GABA, receptor Layer, P., see Grandt, D. (269) 127
(269) 157 Lazarovici, P., see Rasouly, D. (269) 255
Hedlund, P.B., see Billecocq, A. (269) 209
Leprétre, N., see Baron, A. (269) 105
Heuillet, E., Bouaiche, Z., Ménager, J., Dugay, P., Munoz, N., Liston, D.R., see Zorn, S.H. (269) R1
Dubois, H., Amiranoff, B., Crespo, A., Lavayre, J., Blanchard,
Lorinet, A.-M., Javoy-Agid, F., Laburthe, M. and Amiranoff, B.
J.-C. and Doble, A.
Galanin receptors in human hypothalamus: biochemical and
The human galanin receptor: ligand-binding and functional char- structural analysis (269) 59
acteristics in the Bowes melanoma cell line (269) 139
Ludvigsdottir, G., see Adan, R.A.H. (269) 331
Hietala, J., see Kuoppamaki, M. (269) 201
Hill, D.R., see Pinnock, R.D. (269) 73
Holst, J.J., see Schepp, W. (269) 183 Madden, Z., see Pinnock, R.D. (269) 73
Honda, K., see Saita, Y. (269) 249 Madden, Z., see Suman-Chauhan, N. (269) 65
Honma, Y., see Saita, Y. (269) 249 Mak, J.C.W., Grandordy, B. and Barnes, P.J.
Hruby, V.J., see Knapp, R.J. (269) 133 High affinity [*H]formoterol binding sites in lung: characteriza-
tion and autoradiographic mapping (269) 35
Malatynska, E., see Knapp, R.J. (269) 133
Ikeda, U. and Shimada, K.
Marks, M.J., see Firestone, J.A. (269) 177
Nitric oxide release from rat aortic smooth muscle cells is not
Marvizon, J.-C. and Baudry, M.
attenuated by angiotensin converting enzyme inhibitors (269) 319
Allosteric interactions and modulator requirement for NMDA
Imanishi, N., see Koike, H. (269) 299
receptor function (269) 165
Inoue, K., see Nakazawa, K. (269) 375
Massotti, M., see Roscetti, G. (269) 17
Ishikawa, M., Ouchi, Y., Han, S.-z., Akishita, M., Kozaki, K., Toba,
Mayne, N.G., see Sharp, R.L. (269) R5
K., Namiki, A., Yamaguchi, T. and Orimo, H.
McCauley, L.D., see Hawkinson, J.E. (269) 157
Parathyroid hormone-related protein reduces cytosolic free Ca**
Ménager, J., see Heuillet, E. (269) 139
level and tension in rat aortic smooth muscle (269) 311
Mercer, L.D., see Beart, P.M. (269) 193
Iwami, M., see Aramori, I. (269) 277
Michel, M.C., see Grandt, D. (269) 127
Iwao, H., see Ohta, K. (269) 115
Miller, S., Bridges, R.J., Chamberlin, A.R. and Cotman, C.W.
Pharmacological dissociation of glutamatergic metabotropic sig-
Jacquemin-Sablon, A., see Agbotounou, W.K. (269) 1
nal transduction pathways in cortical astrocytes (269) 235
Jarrott, B., see Beart, P.M. (269) 193 Mironneau, J., see Baron, A. (269) 105
Javoy-Agid, F., see Lorinet, A.-M. (269) 59 Miura, K., see Ohta, K. (269) 115
Johansen, T.H., see Verdoorn, T.A. (269) 43 Miyamoto, C., see Adachi, M. (269) 225
Johansson, M.H. and Westlind-Danielsson, A. Miyata, K., see Saita, Y. (269) 249
Forskolin-induced up-regulation and functional supersensitivity
Miyazaki, J.-i., see Mogami, H. (269) 293
of dopamine D,long receptors expressed by Ltk™ cells (269) 149
Mogami, H., Shibata, H., Nobusawa, R., Ohnota, H., Satou, F.,
Jones, S.B., see Zorn, S.H. (269) R1
Miyazaki, J.-i. and Kojima, I.
Jongenelen, C.A.M., see Vermeulen, R.J. (269) 121
Inhibition of ATP-sensitive K* channel by a non-sulfonylurea
compound KAD-1229 in a pancreatic B-cell line, MIN 6 cell
Kim, S., see Ohta, K. (269) 115 (269) 293
Kimbrough, C.L., see Hawkinson, J.E. (269) 157 Morikawa, N., see Aramori, I. (269) 277
Klomp, J., see Stam, N.J. (269) 339 Morooka, S., see Koike, H. (269) 299
Author index / European Journal of Pharmacology — Molecular Pharmacology Section 269 (1994) 385-388 387
Mugnaini, M., see Cavanni, P. (269) 9 Roscetti, G., Ambrosio, C., Trabucchi, M., Massotti, M. and Barbac-
Munoz, N., see Heuillet, E. (269) 139 cia, M.L.
Modulatory mechanisms of cyclic AMP-stimulated steroid con-
Nakanishi, S., see Aramori, I. (269) 277 tent in rat brain cortex (269) 17
Nakazawa, K., Akiyama, T. and Inoue, K. Ryan, M.C., see Beart, P.M. (269) 193
Block by apomorphine of acetylcholine receptor channels ex-
pressed in Xenopus oocytes (269) 375 Saita, Y., Yazawa, H., Honma, Y., Nishida, A., Miyata, K. and
Namiki, A., see Ishikawa, M. (269) 311 Honda, K.
Natsume, Y., see Koike, H. (269) 299 Characterization of YM022: its CCK ,/gastrin receptor binding
Ng, G.YK. and George, S.R. profile and antagonism to CCK-8-induced Ca?* mobilization
Dopamine receptor agonist reduces ethanol self-administration in (269) 249
the ethanol-preferring C57BL/6J inbred mouse (269) 365 Satou, F., see Mogami, H. (269) 293
Ng, G.YK., O’Dowd, B.F. and George, S.R. Saulnier-Blache, J.-S., see Bouloumié, A. (269) 95
Genotypic differences in brain dopamine receptor function in the Schepp, W., Schmidtler, J., Riedel, T., Dehne, K., Schusdziarra, V.,
DBA/2J and C57BL/6J inbred mouse strains (269) 349 Holst, J.J., Eng, J.. Raufman, J.-P. and Classen, M.
Nielsen, E.@., see Verdoorn, T.A. (269) 43 Exendin-4 and exendin-(9-39)NH,: agonist and antagonist, re-
Nilius, B., see Gericke, M. (269) 381 spectively, at the rat parietal cell receptor for glucagon-like
Nishida, A., see Saita, Y. (269) 249 peptide-1-(7—36)NH (269) 183
Nobusawa, R., see Mogami, H. (269) 293 Scherrer, D., see Lach, E. (269) 87
Notsu, Y., see Aramori, I. (269) 277 Schiele, J.O. and Schwabe, U.
Characterization of the adenosine receptor in microvascular coro-
O’Callaghan, J.F.X., see Koutsilieri, E. (269) R3 nary endothelial cells (269) 51
O’Donnell, N., see Aramori, I. (269) 277 Schimiczek, M., see Grandt, D. (269) 127
O’Dowd, B.F., see Ng, G.YK. (269) 349 Schlicker, E., see Grandt, D. (269) 127
Ohnota, H., see Mogami, H. (269) 293 Schmidtler, J., see Schepp, W. (269) 183
Ohta, K., Kim, S., Hamaguchi, A., Yukimura, T., Miura, K., Takaori, Schusdziarra, V., see Schepp, W. (269) 183
K. and Iwao, H. Schwabe, U., see Schiele, J.O. (269) 51
Role of angiotensin II in extracellular matrix and transforming Seppala, T., see Kuoppamaki, M. (269) 201
growth factor-81 expression in hypertensive rats (269) 115 Sharp, R.L., Mayne, N.G. and Burnett, J.P.
Oike, M., see Gericke, M. (269) 381 Cyclothiazide differentially modulates human metabotropic gluta-
Okuhara, M., see Aramori, I. (269) 277 mate receptors linked to phosphoinositide hydrolysis stimulation
Olijve, W., see Stam, N.J. (269) 339 in oocytes (269) R5
Ono, S., see Aramori, I. (269) 277 Shi, F., see Borges, N. (269) 243
Oosterom, J., see Adan, R.A.H. (269) 331 Shibata, H., see Mogami, H. (269) 293
Orimo, H., see Ishikawa, M. (269) 311 Shibata, S., Tanaka, T. and Watanabe, S.
Ouchi, Y., see Ishikawa, M. (269) 311 Facilitatory effects of somatostatin on reduced uptake of 2-de-
oxyglucose in cerebral cortical and hippocampal slices from aged
Peterson, P., see Knapp, R.J. (269) 133 rats (269) 269
Pierre, J., see Agbotounou, W.K. (269) 1 Shimada, K., see Ikeda, U. (269) 319
Pinnock, R., see Suman-Chauhan, N. (269) 65 Skeen, G.A., see Filloux, F.M. (269) 325
Pinnock, R.D., Suman-Chauhan, N., Chung, F.-Z., Webdale, L., Smith, K.E., see Borden, L.A. (269) 219
Madden, Z., Hill, D.R. and Woodruff, G.N. Smith, T.L., see Knapp, R.J. (269) 133
Characterization of tachykinin mediated increases in [Ca**], in Stam, N.J., Vanderheyden, P., Van Alebeek, C., Klomp, J., De Boer,
Chinese hamster ovary cells expressing human tachykinin NK, T., Van Delft, A.M.L. and Olijve, W.
receptors (269) 73 Genomic organisation and functional expression of the gene
Pinnola, V., see Cavanni, P. (269) 9 encoding the human serotonin 5-HT,- receptor (269) 339
Prats, H., see Bouloumié, A. (269) 95 Stoof, J.C., see Vermeulen, R.J. (269) 121
Suman-Chauhan, N., Grimson, P., Guard, S., Madden, Z., Chung,
Qin, Z.-H. and Weiss, B. F.-Z., Watling, K., Pinnock, R. and Woodruff, G.
Dopamine receptor blockade increases dopamine D, receptor Characterisation of [!*I][MePhe’]neurokinin B binding to
and glutamic acid decarboxylase mRNAs in mouse substantia tachykinin NK, receptors: evidence for interspecies variance
nigra (269) 25 (269) 65
Suman-Chauhan, N., see Pinnock, R.D. (269) 73
Rakotoarisoa, L., see Baron, A. (269) 105 Syvalahti, E., see Kuoppamaki, M. (269) 201
Rascher, W., see Grandt, D. (269) 127
Rasouly, D. and Lazarovici, P. Takaori, K., see Ohta, K. (269) 115
Staurosporine induces tyrosine phosphorylation of a 145 kDa Tanaka, T., see Shibata, S. (269) 269
protein but does not activate gp140"* in PC12 cells (269) 255 Temple, S.D., see Craig, C.G. (269) 79
Raufman, J.-P., see Schepp, W. (269) 183 Toba, K., see Ishikawa, M. (269) 311
Rausch, W.-D., see Koutsilieri, E. (269) R3 Trabucchi, M., see Roscetti, G. (269) 17
Reeve Jr., J.R., see Grandt, D. (269) 127 Trifilieff, A., see Lach, E. (269) 87
Regunathan, S. and Reis, D.J. Trist, D., see Cavanni, P. (269) 9
Effects of moxonidine, an imidazoline antihypertensive agent, on
second messenger systems in rat brain (269) 273 Umezawa, K., see Agbotounou, W.K. (269) 1
Reis, D.J., see Regunathan, S. (269) 273
Riedel, T., see Schepp, W. (269) 183 Valet, P., see Bouloumié, A. (269) 95
Riederer, P., see Koutsilieri, E. (269) R3 Van Alebeek, C., see Stam, N.J. (269) 339
388 Author index / European Journal of Pharmacology — Molecular Pharmacology Section 269 (1994) 385-388
Van Amsterdam, F.Th.M., see Cavanni, P. (269) 9 Wolters, E.Ch., see Vermeulen, R.J. (269) 121
Van Delft, A.M.L., see Stam, N.J. (269) 339 Wong, M.G., see Beart, P.M. (269) 193
Vanderheyden, P., see Stam, N.J. (269) 339 Woodruff, G., see Suman-Chauhan, N. (269) 65
Verdoorn, T.A., Johansen, T.H., Drejer, J. and Nielsen, E.@. Woodruff, G.N., see Pinnock, R.D. (269) 73
Selective block of recombinant glur6 receptors by NS-102, a novel
non-NMDA receptor antagonist (269) 43 Yamaguchi, T., see Ishikawa, M. (269) 311
Vermeulen, R.J., Jongenelen, C.A.M., Langeveld, C.H., Wolters, Yamamura, H.I., see Knapp, R.J. (269) 133
E.Ch., Stoof, J.C. and Drukarch, B. Yazawa, H., see Saita, Y. (269) 249
Dopamine D, receptor agonists display a different intrinsic activ- Young, J.M., see Young, K.W. (269) 283
ity in rat, monkey and human astrocytes (269) 121 Young, K.W. and Young, J.M.
Potentiation by 1,4-dithiothreitol of histamine-induced inositol
Ward, K.M., see Zorn, S.H. (269) R1 phosphate formation in rat cerebral cortex and human HeLa cells
Watanabe, S., see Shibata, S. (269) 269 (269) 283
Watling, K., see Suman-Chauhan, N. (269) 65 Yukimura, T., see Ohta, K. (269) 115
Webdale, L., see Pinnock, R.D. (269) 73
Weinshank, R.L., see Borden, L.A. (269) 219 Zalewska, T., see Knapp, R.J. (269) 133
Weiss, B., see Qin, Z.-H. (269) 25 Zenkoh, J., see Aramori, I. (269) 277
Westlind-Danielsson, A., see Johansson, M.H. (269) 149 Zorn, S.H., Jones, $.B., Ward, K.M. and Liston, D.R.
White, H.S., see Filloux, F.M. (269) 325 Clozapine is a potent and selective muscarinic M, receptor
White, T.D., see Craig, C.G. (269) 79 agonist (269) R1